October 30, 2017
Novartis expands its oncology arm with AAA
Novartis said on Monday that it wants to buy Advanced Accelerator Applications (AAA), a radiopharmaceutical company that owns and sells…
Pharmaceuticals, Biotechnology and Life Sciences
Category: news
October 27, 2017
Sandoz is seeking approval for use of its biosimilar to Amgen’s Neulasta, EMA to take a look at it
Novartis division Sandoz has gotten acceptance for its biosimilar to Amgen’s Neulasta by the European Medicines Agency (EMA) for regulatory…
October 26, 2017
Russian biotechnology company BIOCAD enters the European market
The largest Russian biotechnology company BIOCAD plans to enter the European market with oncological and autoimmune medicines. So far, there…
October 26, 2017
New biopharma event alongside CPhI Worldwide 2018 in Madrid
UBM’s pharma portfolio will launch a new biopharma event, BioLive, next year in Madrid – specifically for bioprocessing and manufacturing. The new event has been…
October 25, 2017
BD kicks off $60 million expansion of Nebraska manufacturing facility
BD has broken ground on a $60 million upgrade of its Columbus-East facility on Wednesday.
October 25, 2017
UniQure cashes in $91,250,000 from the offering?
Dutch gene therapy company uniQure N.V. on wednesday announced the pricing of its underwritten public offering of 5,000,000 of its ordinary…
October 25, 2017
Ablynx prices $200M public offering, trades on NASDAQ
Belgian Ablynx on Wednesday announced the pricing of its initial U.S. public offering totaling $200 million, from 11,430,000 American Depositary…
October 25, 2017
Sanofi sues Mylan in the USA
Sanofi said Tuesday it filed a patent infringement suit against Mylan in the USA, alleging infringement of 18 patents in its…
October 24, 2017
Telix, ANMI in JV to sell imaging prostate cancer technology
Telix Pharmaceuticals Limited focused on on targeted radiopharmaceuticals or molecularly-targeted radiation (MTR), has partnered up with Advanced Nuclear Medicine Ingredients SA (ANMI).…
October 24, 2017
Novartis divisions in Q3 push income up 10%
Novartis said on Tuesday that its net sales were up 2% with growth in all divisions, which made net income…